跳至主要内容
临床试验/IRCT20240118060726N1
IRCT20240118060726N1已完成2 期

Comparison of the effect of inhaled salbutamol- ipratropium solution with and without inhaled furosemide solution on signs and symptoms, pulmonary function tests and inflammatory biomarkers in patients with exacerbation of chronic obstructive pulmonary disease.

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 92 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Definite diagnosis of exacerbation COPD disease
  • Age range of 20-65 years
  • Stable vital signs
  • Controlled and constant medication regimen during the study

排除标准

  • Moderate to severe heart failure
  • Digestive problems such as severe nausea and vomiting
  • Cancers of the respiratory tract
  • Chronic kidney or liver disease
  • Surgery of the respiratory system over the past year
  • Pregnancy and breastfeeding
  • Allergy to sulfated drugs
  • Withdrawal from participating

研究者

相似试验